Health Numinus Wellness Closes Q3 2021 With $63.2 Million Cash Position, Lab and Trial Advances, and Strategic Expansion into Psychedelic Neurology July 30, 2021
Health Numinus Announces Health Canada Approval of MAPS-Sponsored Open Label Study for MDMA-Assisted Therapy for PTSD July 12, 2021
Health Numinus Wellness To Acquire Neurology Centre of Toronto, Plans to Create Centre for Psychedelic Neurology July 6, 2021
Element Nutritional Sciences Element Receives Initial Purchase Order from Metro and Second Purchase Order from iHerb July 5, 2021
Health Numinus Files U.S. Provisional Patent Application for a Proprietary Rapid Production Process for Psilocybe and Other Psychoactive Fungi Species June 24, 2021
Health Health Canada Approves Expansion of Mydecine’s Cultivation Capabilities for Psilocybin Producing Mushrooms May 25, 2021
Health MindMed Receives FDA Type C Meeting Response for Project Lucy Phase 2b Clinical Trial May 17, 2021
Search
Health
September 3, 2021
July 30, 2021
July 12, 2021
July 6, 2021
July 5, 2021
June 29, 2021
June 29, 2021
June 24, 2021
May 25, 2021
May 17, 2021
